LIBELULA Trademark

Trademark Overview


On Wednesday, April 17, 2024, a trademark application was filed for LIBELULA with the United States Patent and Trademark Office. The USPTO has given the LIBELULA trademark a serial number of 79400586. The federal status of this trademark filing is REGISTERED as of Tuesday, March 25, 2025. This trademark is owned by Debiopharm International SA. The LIBELULA trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Providing medical and scientific research information in the field of pharmaceutical products; carrying out clinical trials for pharmaceutical products; scientific research for medical purposes in the field of endocrinology

Publication of clinical trial results in the field of endocrinology

Pharmaceutical products focused on endocrinology, namely, medical preparations for the treatment of precocious puberty and for participants receiving gonadotropin releasing hormone agonist therapy for central precocious puberty
libelula

General Information


Serial Number79400586
Word MarkLIBELULA
Filing DateWednesday, April 17, 2024
Status700 - REGISTERED
Status DateTuesday, March 25, 2025
Registration Number7734564
Registration DateTuesday, March 25, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements


Goods and ServicesProviding medical and scientific research information in the field of pharmaceutical products; carrying out clinical trials for pharmaceutical products; scientific research for medical purposes in the field of endocrinology
Goods and ServicesPublication of clinical trial results in the field of endocrinology
Translation of Words in MarkThe wording "LIBELULA" has no meaning in a foreign language.
Goods and ServicesPharmaceutical products focused on endocrinology, namely, medical preparations for the treatment of precocious puberty and for participants receiving gonadotropin releasing hormone agonist therapy for central precocious puberty

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDebiopharm International SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameDebiopharm International SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameDebiopharm International SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, July 25, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 29, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, October 30, 2024ASSIGNED TO EXAMINER
Wednesday, November 6, 2024NON-FINAL ACTION WRITTEN
Friday, November 8, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 14, 2024REFUSAL PROCESSED BY MPU
Thursday, November 14, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 30, 2024REFUSAL PROCESSED BY IB
Tuesday, December 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 9, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 25, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 26, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 8, 2025FINAL DISPOSITION PROCESSED
Wednesday, October 8, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 24, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 24, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, December 24, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB